High-value markets TeraPore’s IsoBlock VF virus filtration and Intelligent Membrane technology position them to target high-value biopharma manufacturing segments, including mAbs and cell-derived proteins, suggesting sales opportunities with contract manufacturers and biologics developers pursuing robust downstream purification solutions.

Strategic leadership New leadership appointment as president and COO signals a push toward scaled operations and commercial execution, presenting an opening to engage decision-makers on capacity, process optimization, and long-term partnerships.

Growing funding momentum Recent $10M financing and ongoing funding history support acceleration of product launches and market expansion, indicating readiness for pilot programs, field trials, and co-development opportunities with early adopters.

Nanofiltration edge Proprietary nanofiltration membranes enabling high-capacity, high-yield separations can be positioned to process larger bioprocess flows and complex antibody constructs, appealing to flow-level optimization teams and process development groups.

Geographic & ecosystem fit Located in South San Francisco within biotech hub, with seasoned advisory board, offering nearby collaboration potential with regional biopharma clusters, contract manufacturers, and academic-industry partnerships for rapid validation and deployment.